Urolithin A attenuates pulmonary fibrosis via the PI3K/AKT/mTOR pathway: Evidence from network pharmacology and experimental validation
UA exerts therapeutic effects on PF by targeting the PI3K/AKT/mTOR pathway, particularly through the inhibition of AKT1 phosphorylation. These findings indicate that UA has potential as a therapeutic candidate for PF and provide a novel perspective for utilizing gut microbiota metabolites in the treatment of fibrotic diseases. Further studies are needed to elucidate the precise mechanisms of UA.
Authors
- Wei Wang (ORCID: https://orcid.org/0000-0002-9485-583X)
- Kai Gao (ORCID: https://orcid.org/0009-0001-1209-1638)
- Zhaoxing Dong (ORCID: https://orcid.org/0000-0003-1336-149X)
- Jiangpo Ma
Institutions
- Ningbo No. 2 Hospital (CN)
- Ningbo No.6 Hospital (CN)
Publication Details
- Journal
- Biochemical and Biophysical Research Communications
- Published
- 2025-06-17
- DOI
- https://doi.org/10.1016/j.bbrc.2025.152219
- Citations
- 1
- Primary Topic
- Pomegranate: compositions and health benefits
- Type
- article
- Field-Weighted Citation Impact
- 1.12